Management of Hepatitis C Infection

  • Authors: Jordan J. Feld, MD, MPH; Hemant Shah, MD, MScCH HPTE (More Info)
  • Editor In Chief: Stefan Zeuzem, MD
  • Last Reviewed: 7/24/18 (What's New)

Summary

  • AASLD/IDSA guidelines recommend DAA-based regimens for genotype 1 HCV–infected patients according to subgenotype, presence of baseline NS5A resistance associated mutations, and cirrhosis status (Table 29) (Table 30) (Management Guidelines)[AASLD-IDSA HCV]
  • EASL guidelines also recommend DAA-based regimens for treatment-naive and interferon/ribavirin-experienced patients with genotype 1 HCV infection according to subgenotype and cirrhosis status (Table 31) (Management Guidelines)[EASL HCV]

Action required